Laura A Williams, the Chief Patient Officer of $ARDX, sold 30,000 shares of the company on 08-26-2025 for an estimated $183,630. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.6% of their shares of this class of stock. Following this trade, they now own 366,322 shares of this class of $ARDX stock.
$ARDX Insider Trading Activity
$ARDX insiders have traded $ARDX stock on the open market 21 times in the past 6 months. Of those trades, 4 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:
- DAVID M MOTT has made 4 purchases buying 881,377 shares for an estimated $3,403,196 and 0 sales.
- MICHAEL RAAB (President & CEO) has made 0 purchases and 5 sales selling 217,504 shares for an estimated $1,053,598.
- LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 4 sales selling 92,682 shares for an estimated $553,025.
- ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 17,815 shares for an estimated $101,034.
- MIKE KELLIHER (Chief Business Officer) has made 0 purchases and 2 sales selling 19,939 shares for an estimated $91,402.
- JUSTIN A RENZ (Chief Financial Officer) has made 0 purchases and 2 sales selling 14,255 shares for an estimated $71,200.
- ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,833 shares for an estimated $59,102.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARDX Hedge Fund Activity
We have seen 107 institutional investors add shares of $ARDX stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 9,919,066 shares (-39.7%) from their portfolio in Q2 2025, for an estimated $38,882,738
- EVENTIDE ASSET MANAGEMENT, LLC removed 5,600,764 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,499,751
- MILLENNIUM MANAGEMENT LLC added 5,197,967 shares (+80.4%) to their portfolio in Q2 2025, for an estimated $20,376,030
- MARSHALL WACE, LLP added 2,866,843 shares (+34.2%) to their portfolio in Q2 2025, for an estimated $11,238,024
- BLACKROCK, INC. added 2,799,200 shares (+15.6%) to their portfolio in Q2 2025, for an estimated $10,972,864
- BANK OF AMERICA CORP /DE/ added 2,600,080 shares (+88.8%) to their portfolio in Q2 2025, for an estimated $10,192,313
- JONES FINANCIAL COMPANIES LLLP added 1,832,320 shares (+16861.3%) to their portfolio in Q2 2025, for an estimated $7,182,694
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ARDX Analyst Ratings
Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/18/2025
- Citigroup issued a "Buy" rating on 05/02/2025
- Scotiabank issued a "Sector Outperform" rating on 03/07/2025
- Ladenburg Thalmann issued a "Buy" rating on 03/07/2025
To track analyst ratings and price targets for $ARDX, check out Quiver Quantitative's $ARDX forecast page.
$ARDX Price Targets
Multiple analysts have issued price targets for $ARDX recently. We have seen 7 analysts offer price targets for $ARDX in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Christopher Raymond from Piper Sandler set a target price of $9.0 on 08/06/2025
- Laura Chico from Wedbush set a target price of $14.0 on 08/05/2025
- Ryan Deschner from Raymond James set a target price of $12.0 on 08/05/2025
- Matthew Caufield from HC Wainwright & Co. set a target price of $10.0 on 06/18/2025
- Yigal Nochomovitz from Citigroup set a target price of $10.0 on 05/02/2025
- Aydin Huseynov from Ladenburg Thalmann set a target price of $11.0 on 03/07/2025
- Louise Chen from Scotiabank set a target price of $15.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
